238743-29-8Relevant articles and documents
Synthesis method of substituted benzaldehyde acetal
-
, (2022/03/31)
The invention provides a synthetic method of substituted benzaldehyde acetal. The substituted benzaldehyde acetal has a structure as shown in a formula (I), wherein X1 and X2 are respectively independently selected from halogen or vacancy, and n is 1 or 2; the synthesis method comprises the following steps: in an inert gas atmosphere, carrying out a reduction reaction on substituted nitrobenzene in the presence of a nickel catalyst to obtain substituted aniline, and carrying out the reduction reaction in a first solvent: in a second solvent, carrying out an oxidation denitrification rearrangement reaction on the substituted aniline, paraformaldehyde and an oxidizing agent to obtain substituted benzaldoxime; substituted benzaldoxime, hydroquinone and dihydric alcohol are subjected to an aldehyde group protection reaction in the presence of a solid acid catalyst to obtain substituted benzaldehyde acetal, wherein the solid acid catalyst is a solid superacid compound. The substituted benzaldehyde acetal prepared by the method has high yield and purity, the reaction raw materials are simple and easy to obtain, the reaction conditions are mild, the cost is low, and large-scale production is facilitated.
Novel selective ido1 inhibitors with isoxazolo[5,4-d]pyrimidin-4(5h)-one scaffold
?vajger, Urban,Bratkovi?, Toma?,Dol?ak, Ana,Gobec, Stanislav,Mlinari?, Larisa,Ogorevc, Eva,Sova, Matej
, (2021/04/02)
Indoleamine 2,3-dioxygenase 1 (IDO1) is a promising target in immunomodulation of several pathological conditions, especially cancers. Here we present the synthesis of a series of IDO1 inhibitors with the novel isoxazolo[5,4-d]pyrimidin-4(5H)-one scaffold. A focused library was prepared using a 6-or 7-step synthetic procedure to allow a systematic investigation of the structure-activity relationships of the described scaffold. Chemistry-driven modifications lead us to the discovery of our best-in-class inhibitors possessing p-trifluoromethyl (23), p-cyclohexyl (32), or p-methoxycarbonyl (20, 39) substituted aniline moieties with IC50 values in the low micromolar range. In addition to hIDO1, compounds were tested for their inhibition of indoleamine 2,3-dioxygenase 2 and tryptophan dioxygenase, and found to be selective for hIDO1. Our results thus demon-strate a successful study on IDO1-selective isoxazolo[5,4-d]pyrimidin-4(5H)-one inhibitors, defining promising chemical probes with a novel scaffold for further development of potent small-molecule immunomodulators.
Design, synthesis, and in vitro evaluation of novel triazole analogues featuring isoxazole moieties as antifungal agents
Chai, Xiaoyun,Ding, Zichao,Hao, Yumeng,Jiang, Yuanying,Jin, Yongsheng,Ni, Tingjunhong,Wang, Ruilian,Wang, Ruina,Wang, Ting,Xie, Fei,Yu, Shichong,Zhang, Dazhi
supporting information, (2020/06/17)
In order to develop novel antifungal agents, based on our previous work, a series of (2R,3R)-3-((3-substitutied-isoxazol-5-yl)methoxy)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl) butan-2-ol (a1-a26) were designed and synthesized. All of the compounds exhibited good in vitro antifungal activities against eight human pathogenic fungi. Among them, compound a6 showed excellent inhibitory activity against Candida albicans and Candida parasilosis with MIC80 values of 0.0313 μg/mL. In addition, compounds a6, a9, a12, a13 and a14 exhibited moderate inhibitory activities against fluconazole-resistant isolates with MIC80 values ranging from 8 μg/mL to 16 μg/mL. Furthermore, compounds a6, a12 and a23 exhibited low inhibition profiles for CYP3A4. Clear SARs were analyzed, and the molecular docking experiment was carried out to further investigate the relationship between a6 and the target enzyme CYP51.
